Clinical Trial

Exercise and/or HMB in Older Diabetes With Low Muscle Mass

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The investigators aimed to examine if β-hydroxy-β-methylbutyrate (HMB) supplementation enhances the effects of exercise on muscle mass, physical performance and insulin resistance and observe potential residual effects in older diabetes with low muscle mass, and to find the optimal treatment plan.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-26.
Trial Details
NCT Number NCT07142941
Lead Sponsor Wu Shangling
Conditions Diabetes, Low Muscle Mass
Enrollment 120 participants
Start Date 2026-04-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-31